Gan & Lee Pharmaceuticals. (SHA: 603087)

Gan & Lee Pharmaceuticals. Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	25,358	31,066	18,429	39,499	74,247	-
Market Cap Growth	14.98%	68.57%	-53.34%	-46.80%	-	-
Enterprise Value	20,295	26,918	13,463	34,935	70,382	-
Last Close Price	42.47	51.86	32.09	68.84	128.99	-
PE Ratio	43.08	91.35	-	27.19	60.33	-
Forward PE	27.22	52.08	11.40	25.81	50.01	-
PS Ratio	8.49	11.91	10.76	10.94	22.08	-
PB Ratio	2.34	2.89	1.92	3.88	8.31	-
P/TBV Ratio	2.66	2.97	1.98	4.00	8.53	-
P/FCF Ratio	168.23	-	-	102.30	112.63	-
P/OCF Ratio	44.70	283.83	62.12	36.63	59.81	-
EV/Sales Ratio	6.89	10.32	7.86	9.67	20.94	-
EV/EBITDA Ratio	42.04	68.22	-	22.24	44.70	-
EV/EBIT Ratio	81.30	149.52	-	25.13	49.75	-
EV/FCF Ratio	134.64	-	-	90.48	106.77	-
Debt / Equity Ratio	0.00	0.00	0.00	0.00	-	-
Debt / EBITDA Ratio	0.01	0.02	-	0.01	-	-
Debt / FCF Ratio	0.02	-	-	0.04	-	-
Asset Turnover	0.26	0.23	0.16	0.35	0.43	0.54
Inventory Turnover	0.84	0.96	0.68	0.70	0.64	0.55
Quick Ratio	6.62	6.77	6.05	12.65	13.14	5.66
Current Ratio	8.04	7.98	6.97	14.15	14.54	6.79
Return on Equity (ROE)	5.51%	3.35%	-4.45%	15.21%	17.08%	23.97%
Return on Assets (ROA)	1.35%	1.01%	-3.94%	8.54%	11.38%	15.50%
Return on Capital (ROIC)	1.48%	1.11%	-4.27%	9.09%	12.27%	17.05%
Earnings Yield	2.32%	1.09%	-2.38%	3.68%	1.66%	-
FCF Yield	0.59%	-1.43%	-3.73%	0.98%	0.89%	-
Dividend Yield	1.19%	0.39%	-	0.44%	0.31%	-
Payout Ratio	20.36%	-	-	15.46%	16.30%	-
Buyback Yield / Dilution	-3.48%	-0.59%	-0.46%	-5.28%	-5.43%	-0.09%
Total Shareholder Return	-2.29%	-0.20%	-0.46%	-4.84%	-5.12%	-0.09%

Source: S&P Capital IQ. Standard template. Financial Sources.